Confirming the Diagnosis: Tests and Pathology

Diagnosing Congenital Dyserythropoietic Anemia Type I (CDA I) is a complex process that combines blood tests, genetic analysis, and sometimes a detailed look at the bone marrow. Because CDA I is so rare, the diagnostic journey often involves ruling out more common conditions that “mimic” its symptoms ^[1][2].

Initial Blood Work: The First Clues

The diagnostic process usually begins with a Complete Blood Count (CBC) and other standard blood tests. In CDA I, doctors look for several supportive patterns:

• Macrocytic Anemia: This means the red blood cells are larger than normal (macrocytosis). While most people think of anemia as “too few” cells, in CDA I, the cells that do make it into the bloodstream are often unusually large ^[3][4].
• Relative Reticulocytopenia: Reticulocytes are young red blood cells. In most anemias, the body pumps out more reticulocytes to compensate for the loss. In CDA I, the “relative” number of these young cells is surprisingly low because the bone marrow is struggling to produce them in the first place ^[5][3].
• Signs of Ineffective Production: High levels of bilirubin and LDH (lactate dehydrogenase) along with low haptoglobin indicate that red blood cells are being destroyed or are dying before they can mature ^[5][6].

These findings are supportive clues, but they are not diagnostic on their own and can reflect other processes (like B12/folate deficiency or thyroid disease).

Genetic Testing: The Preferred Standard

Today, genetic testing is the preferred method for establishing a definitive diagnosis. It is less invasive than a bone marrow biopsy and can often provide a clear answer ^[7][4].

To confirm CDA I, testing generally seeks to identify two pathogenic mutations (one from each parent) in one of two specific genes:

1. CDAN1: The most common cause of CDA I ^[8].
2. CDIN1 (formerly known as C15orf41): A less common but equally important gene to test ^[8][4].

Important Caveats:

• Variants of Uncertain Significance (VUS): A VUS is a gene change whose clinical impact is not yet known. A VUS alone does not confirm CDA I.
• Missing Mutations: A standard panel might miss large genetic deletions or duplications. A negative limited panel does not entirely exclude the diagnosis, and broader sequencing may be needed ^[2].

Many experts now use Next-Generation Sequencing (NGS) panels that screen for many different hereditary anemias at once ^[2][1].

Bone Marrow Pathology: A Closer Look

If genetic testing is inconclusive or unavailable, a doctor may perform a bone marrow aspirate to look at the cells under a microscope. CDA I has characteristic “footprints” in the marrow, though they must be interpreted by an experienced hematopathologist.

Light Microscopy

Using a standard microscope, a pathologist looks for:

• Erythroid Hyperplasia: The marrow is “overcrowded” with early-stage red blood cells ^[9].
• Binucleated Erythroblasts: Cells that mistakenly have two centers (nuclei) instead of one ^[9].
• Internuclear Chromatin Bridges: A classic sign where a thin “thread” of genetic material connects the centers of two different cells. This was found in about 79% of confirmed CDA I cases in one study ^[9].

Electron Microscopy (EM)

While electron microscopy is not routinely required for every patient when molecular testing is informative, it can reveal the ultrastructure of the cells:

• “Swiss Cheese” Chromatin: A highly characteristic sign of CDA I is spongy heterochromatin. The center of the cell looks full of holes, similar to Swiss cheese ^[9].
• Nuclear Pores: The pores in the cell’s center may appear unusually wide ^[9].

Avoiding Misdiagnosis

Because many anemias look similar, CDA I is often mistaken for other conditions. Your medical team must specifically rule out:

• Pyruvate Kinase Deficiency (PKD): This is the most common mimic. PKD can even cause some of the same bone marrow changes as CDA I. Additional PKLR gene testing may be needed ^[7][10].
• Thalassemia and Hemoglobinopathies: A common group of blood disorders that can also cause ineffective cell production ^[11].
• Diamond-Blackfan Anemia (DBA): While DBA is characterized by a marked paucity of erythroid precursors in the marrow, it is part of the standard differential diagnosis for congenital anemias ^[12].

Completeness Checklist

A thorough diagnostic workup for CDA I might include the following:

• [ ] Complete Blood Count (CBC) with MCV (cell size) and absolute reticulocyte count ^[3].
• [ ] Hemolysis markers (Bilirubin, LDH, Haptoglobin) ^[5].
• [ ] Exclusion of reversible causes (Vitamin B12 or folate deficiency, thyroid assessment, hemoglobinopathy testing, and Direct Antiglobulin Test).
• [ ] Iron studies (Ferritin and Transferrin Saturation) ^[13].
• [ ] Genetic Testing for both CDAN1 and CDIN1 ^[8].
• [ ] Family History to check for other affected relatives or carrier patterns ^[14].
• [ ] Bone Marrow Review (if genetics are unclear), preferably by a pathologist experienced in rare anemias ^[9].